Evaluation of extended dosing intervals versus weekly dosing of darbepoetin alfa (DA): A phase 2 study in cancer patients (pts) with chemotherapy-induced anemia (CIA)

Journal article

Peer reviewed

T. Rearden, L. Schwartzberg, B. Mirtsching, D. Tomita, T. Lillie, R. Burkes and Peter T. Silberstein

European Journal of Cancer. Supplement, Vol.5(4), pp.154-154

09/2007

Metrics

4 Record Views

Title: Evaluation of extended dosing intervals versus weekly dosing of darbepoetin alfa (DA): A phase 2 study in cancer patients (pts) with chemotherapy-induced anemia (CIA)
Creators: T. Rearden (Author)
L. Schwartzberg (Author)
B. Mirtsching (Author)
D. Tomita (Author)
T. Lillie (Author)
R. Burkes (Author)
Peter T. Silberstein (Author) - Creighton University
Publication Details: European Journal of Cancer. Supplement, Vol.5(4), pp.154-154
Number of pages: 154-154
Identifiers: 991005931541702656
Academic Unit: School of Medicine; Hematology & Oncology
Resource Type: Journal article